Scilex gains on spinoff plans for pharma subsidiary [Seeking Alpha]
Scilex Holding Company (SCLX)
Company Research
Source: Seeking Alpha
developer announced plans to spin off or seek a public listing of its wholly owned subsidiary, Scilex Pharmaceuticals, in the U.S. or overseas. Scilex ( NASDAQ: SCLX ) said that its board of directors has greenlighted the plans as part of a broader move to maximize the value of Scilex Pharmaceuticals, whose portfolio includes three FDA-approved nonopioid pain products and a next-gen pain candidate called SP-103. The Palo Alto, California-based company added that the potential value of Scilex Pharma could exceed that of its parent, and a spinoff or public listing would help unlock their actual values. A potential strategic transaction and/or a dividend of Scilex Pharma common stock to shareholders of Scilex ( SCLX are also on the cards. More on Scilex Holding Company Seeking Alpha's Quant Rating on Scilex Holding Company Historical earnings data for Scilex Holding Company Financial information for Scilex Holding Company Recommended For You Comments
Show less
Read more
Impact Snapshot
Event Time:
SCLX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SCLX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SCLX alerts
High impacting Scilex Holding Company news events
Weekly update
A roundup of the hottest topics
SCLX
News
- Scilex Holding Company Announces Presentation of Data at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 14 – 19, 2024 [Yahoo! Finance]Yahoo! Finance
- Scilex Holding Company Announces Presentation of Data at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 14 – 19, 2024GlobeNewswire
- Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the PreviouslAcquire Media Monitor
- Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the PreviouslGlobeNewswire
- Scilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of Scilex Holding Company, Announces Successful End of Phase II Meeting with FDA Leading to an Agreed Path Forward to NDA Upon Completion of Phase III Trials for Blockbuster Product Candidate, SP-103 (GlobeNewswire
SCLX
Earnings
- 8/13/24 - Miss
SCLX
Analyst Actions
- 10/21/24 - HC Wainwright
SCLX
Sec Filings
- 11/20/24 - Form 424B3
- 11/20/24 - Form 424B3
- 11/20/24 - Form 8-K
- SCLX's page on the SEC website